Part:BBa_K1614017
software generated kanamycin aptamer (candidate 3)
Notice: Functional DNA
This part is a sequence of a functional ssDNA. It is only active as single-stranded DNA. It can not be cloned into a plasmid. For use order it as a DNA oligo.
Aptamer binding kanamycin created by the MAWS (http://2015.igem.org/Team:Heidelberg/software/maws) Software from iGEM Team Heidelberg.
Characterization of this part by Gold nanoparticle-based colorimetric detection
Team DUT China A 2019 characterized this part to find out whether this part can bind to kanamycin, we put forward a plan, Gold nanoparticle-based colorimetric detection.
Principle
Gold nanoparticles (Au NPs) covered by Citrate ion are charged negatively and they repel each other, remaining dispersive in the solution. After adding NaCl into this solution system, the double electrode layer of the Au NPs are destroyed and they tend to being coagulated, resulting the color of the solution changes from red to blue-purple, and the spectrum of the solution shifts red. The absorbance of 620nm obviously increase. However, short ssDNAs are readily adsorbed onto the surface of AuNPs without any modification and that such ssDNA-treated AuNPs are more stable than untreated ones. Adding aptamers into the system, the citrate root of nano gold surface is replaced. AuNPs can still remain negetively charged instead of being coagulated even if there is NaCl due to the non-specific interaction between DNA side chain phosphate groups and Au NPs, keeping the solution color red. When kanamycin, the determinand is added in to the solution, the adaptor configuration changes and falls off the surface of the Au NPs because there is specific affinity between the kanamycn and the aptamers. AuNPs is going to coagulate. The changing concentrations of kanamycin lead to the changing AuNPs solution spectra. Adopting this method, the specific binding of the aptamer to kanamycin can be tested and the kanamycin in the solution can be easily and quickly detected.
Protocol, Results and Discussion
Experiment 1: Preparation for Au NPs
Add 125mL HAuCl(1mM) water solution to 250mL round bottom flask. Heat it until boils then quickly add 12.5 mL (38.8mM) sodium citrate solution into this system. Heat for 10min, remove the heating sleeve, stir for 15min. Cool to room temperature and obtain Au NPs with particle size of about 13nm.
Experiment 2: Exploration on the least concentration of NaCl to precipitate a certain concentration of Au NPs
We fabricate Au NPs systems with different concentration of NaCl in 96 well plates and measure their absorbance ratios at wavelengths of 520 nm and 620 nm, which is shown in Figure.1 and Figure.2.
Obviously, the trend line of A620/A520 reaches a plateau when the concentration of NaCl comes to 0.045 M. We can assume that 0.045 M of NaCl is able to precipitate all the Au NPs in this system. In the following experiments, we will make the concentration of NaCl at 0.075 M in every system.
Experiment 3: Explorations on the least concentration of Aptamer K3 to protect all the Au NPs from being precipitated
Once there are extra aptamers in the solution system, they will bond to the kanamycin while the Au NPs are still totally protected, which will not lead to a change on A620/A520. We don’t want this happen. Therefore, we must ensure that the aptamers at the working concentration are not excessive.
We fabricate Au NPs systems with different concentration of Aptamer K3 in 96 well plates when the NaCl is 0.075 M and measure their absorbance ratios at wavelengths of 520 nm and 620 nm, which is shown in Figure.3.
Obviously, the trend line of A620/A520 is likely to just reach a plateau when the concentration of Aptamer K3 comes to 0.20 μM. We can assume that Aptamer K3 at this amount are just enough to protect all the Au NPs at 150 nM. In the following experiment 4, we will make the concentration of Aptamer at 0.20 μM in the system.
Experiment 4: Characterization of Aptamer
K3
Incubate 150 nM of AuNP and 0.20μM of Aptamer K3 for 30min at 37℃, with system volume being 200 μL. Add different concentrations of kanamycin into the system with the final concentration of kanamycin between 0 and 0.45 μM. Add 5μL, 3M of NaCl solution, making its final concentration at 0.075 M. All these steps are done in 96-well plates. Measure the absorbance at 620nm and 520nm by uv-vis spectrometer, and the changes of A 620 / A 520 are recorded and analyzed, which is shown in Figure.4.
Conclusion
As the trend line in Figure.4 shows, A620/A520 changes as the concentration of kanamycin changes and finally reaches a plateau, indicating that the changing concentrations of kanamycin lead to the changing AuNPs solution spectra. We can make a conclusion that there is specific binding between Aptamer K3 and kanamycin.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
| None |